Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for Progress

里奥格兰德河谷阿尔茨海默病少数族裔老龄化研究资源中心:合作促进进步

基本信息

项目摘要

Summary OVERALL Alzheimer´s disease (AD) is an aging-associated disorder that disproportionately impacts Hispanics/Latinos, who exhibit AD rates 1.5 times higher and average onset 7 years earlier than do older whites. Predicted growth of the US Hispanic population, particularly faster in Texas, portends further exacerbation of the disproportion- ate health and economic burdens of elevated AD in Hispanics. There is a shortage of researchers focused on AD and related disorders (ADRD) in Hispanics, particularly from underrepresented racial/ethnic groups. To overcome these barriers, the proposed AD Resource Center for Minority Aging Research (AD-RCMAR) at the University of Texas Rio Grande Valley (UTRGV), one of the nation's largest Hispanic-serving institutions, will combine evidence-based mentoring and support mechanisms to develop and promote a first-rate regional and national cadre of researchers, particularly from under-represented groups, to analyze the complex mecha- nisms and interacting factors that contribute to Hispanics' disparate vulnerabilities to AD. The Center will sup- port identification of pathways and developmental time points at which changes in social circumstances and behavior can exert the largest favorable impacts on prevention and progression of AD among Hispanics. The UTRGV AD-RCMAR will exploit its unique resources to develop infrastructure and data collections that will at- tract and support researchers from multiple disciplines and at different scientific career stages, and allow them to conduct research aimed at reducing the impacts of AD on Hispanics. The socio-demographic profile of UTRGV reflects that of its local community, positioning the Center uniquely to advance studies of disparities in health and health care and contribute innovative solutions to improve minorities' health. We will achieve the Center's goals via 4 specific aims: 1) to identify, engage, mentor, and provide high-quality training and individu- alized career development support to outstanding faculty, especially from underrepresented groups; 2) to sup- port innovative, high-impact multidisciplinary pilot projects; 3) to provide expertise and resources for culturally- sensitive measurement and analysis of cognitive risk factors in older Hispanics, including behavioral, neuro- psychological, neuroimaging, and cardiovascular and genetic traits; and 4) to create the necessary expertise and resources to establish longitudinal research cohorts of older Hispanics and their families. We will achieve these aims through the creation of 4 Cores (Administrative; Research Education; Analysis; and Community Liaison/Recruitment) to support AD research. The Center will build upon the experience of investigators at the UTRGV Institute of Neuroscience and collaborators at the South Texas Diabetes & Obesity Institute, and Washington University's AD Research Center.
总结 阿尔茨海默病(AD)是一种与衰老相关的疾病,对西班牙裔/拉丁裔的影响不成比例, 他们的AD发病率比老年白人高1.5倍,平均发病时间早7年。预测生长 美国西班牙裔人口的增长,特别是在得克萨斯州,预示着比例失调的进一步加剧- 在西班牙裔人中,AD的健康和经济负担增加。缺乏研究人员专注于 西班牙裔AD和相关疾病(ADRD),特别是来自代表性不足的种族/族裔群体。到 为了克服这些障碍,拟议中的少数民族老龄化研究AD资源中心(AD-RCMAR) 德克萨斯大学格兰德河谷分校(UTRGV)是美国最大的西班牙裔服务机构之一, 将联合收割机循证指导和支持机制结合起来,发展和促进一流的区域和 国家骨干研究人员,特别是来自代表性不足的群体,分析复杂的机制, nisms和相互作用的因素,有助于西班牙裔的不同脆弱性,以AD。该中心将提供- 端口识别的途径和发展的时间点,在社会环境的变化, 行为可以发挥最大的有利影响,预防和发展的西班牙裔美国人的AD。的 UTRGV AD-RCMAR将利用其独特的资源开发基础设施和数据收集, 吸引和支持来自多个学科和不同科学生涯阶段的研究人员,并允许他们 进行旨在减少AD对西班牙裔的影响的研究。社会人口概况 UTRGV反映了当地社区的情况,将该中心定位为独特的,以推进对 并为改善少数群体的健康提供创新解决方案。我们将实现 中心的目标通过4个具体目标:1)识别,参与,导师,并提供高质量的培训和个人, 为优秀教师提供职业发展支持,特别是来自代表性不足的群体; 2) 港口创新、影响力大的多学科试点项目; 3)为文化- 敏感的测量和分析老年西班牙裔人的认知风险因素,包括行为,神经, 心理学、神经影像学、心血管和遗传特征; 4)创造必要的专业知识 和资源,以建立纵向研究队列的老年西班牙裔和他们的家庭。我们将实现 通过创建4个核心(行政、研究教育、分析和社区)实现这些目标 联络/招聘),以支持AD研究。该中心将利用研究人员在 UTRGV神经科学研究所和南德克萨斯糖尿病与肥胖研究所的合作者, 华盛顿大学AD研究中心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gladys E. Maestre其他文献

Association of brain arterial diameters with demographic and anatomical factors in a multi-national pooled analysis of cohort studies
多国队列研究汇总分析中脑动脉直径与人口和解剖因素的关联
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    V. D. Del Brutto;Farid Khasiyev;Minghua Liu;Antonio Spagnolo;Ye Qiao;Jesus D Melgarejo Arias;Vanessa A Guzman;K. Igwe;Danurys L Sanchez;Howard Andrews;Clarissa D. Morales;Meagan T Farrell;Darina T. Bassil;Sudha Seshadri;R. Wagner;Victor Mngomezulu;Jennifer Manly;Mitchell S. V. Elkind;Lisa F. Berkman;J. R. Romero;Gladys E. Maestre;O. D. Del Brutto;A. Brickman;Narayanaswamy Venketasubramanian;Christopher Chen;Caroline Robert;S. Hilal;Tatjana Rundek;B. Wasserman;Jose Gutierrez
  • 通讯作者:
    Jose Gutierrez
Effects of missing data imputation methods on univariate blood pressure time series data analysis and forecasting with ARIMA and LSTM
  • DOI:
    10.1186/s12874-024-02448-3
  • 发表时间:
    2024-12-26
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Nicholas Niako;Jesus D. Melgarejo;Gladys E. Maestre;Kristina P. Vatcheva
  • 通讯作者:
    Kristina P. Vatcheva
Isolated systolic hypertension: a new challenge in medicine
单纯性收缩期高血压:医学的新挑战
  • DOI:
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Tulio Sulbarán;E. Silva;Gladys E. Maestre
  • 通讯作者:
    Gladys E. Maestre
Impacts of imageability of architecture on brain health: A systematic literature review
建筑的形象性对大脑健康的影响:系统文献综述
  • DOI:
    10.1016/j.landurbplan.2024.105286
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    9.200
  • 作者:
    Cristian A. Maestre;Shana Garza;Yohany Albornoz;Silvia Mejia-Arango;Jesus D. Melgarejo;Gladys E. Maestre
  • 通讯作者:
    Gladys E. Maestre

Gladys E. Maestre的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gladys E. Maestre', 18)}}的其他基金

Community Engagement Core
社区参与核心
  • 批准号:
    10749786
  • 财政年份:
    2023
  • 资助金额:
    $ 65.47万
  • 项目类别:
South Texas Alzheimer's Disease Center
南德克萨斯阿尔茨海默病中心
  • 批准号:
    10472637
  • 财政年份:
    2021
  • 资助金额:
    $ 65.47万
  • 项目类别:
South Texas Alzheimer's Disease Center
南德克萨斯阿尔茨海默病中心
  • 批准号:
    10270723
  • 财政年份:
    2021
  • 资助金额:
    $ 65.47万
  • 项目类别:
South Texas Alzheimer's Disease Center
南德克萨斯阿尔茨海默病中心
  • 批准号:
    10662308
  • 财政年份:
    2021
  • 资助金额:
    $ 65.47万
  • 项目类别:
Integration of Socio-Spatial Data for Neighborhoods with Multi-omic profiles to Identify and Mitigate Factors Affecting Risk of ALzheimer's Disease
将社区的社会空间数据与多组学概况相整合,以识别和减轻影响阿尔茨海默病风险的因素
  • 批准号:
    10095572
  • 财政年份:
    2020
  • 资助金额:
    $ 65.47万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730146
  • 财政年份:
    2018
  • 资助金额:
    $ 65.47万
  • 项目类别:
Administrative Core Rio Grande Valley AD-RCMAR
里奥格兰德河谷行政核心 AD-RCMAR
  • 批准号:
    10241361
  • 财政年份:
    2018
  • 资助金额:
    $ 65.47万
  • 项目类别:
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for Progress
里奥格兰德河谷阿尔茨海默病少数族裔老龄化研究资源中心:合作促进进步
  • 批准号:
    10461921
  • 财政年份:
    2018
  • 资助金额:
    $ 65.47万
  • 项目类别:
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for Progress
里奥格兰德河谷阿尔茨海默病少数族裔老龄化研究资源中心:合作促进进步
  • 批准号:
    9532548
  • 财政年份:
    2018
  • 资助金额:
    $ 65.47万
  • 项目类别:
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for Progress
里奥格兰德河谷阿尔茨海默病少数族裔老龄化研究资源中心:合作促进进步
  • 批准号:
    10730145
  • 财政年份:
    2018
  • 资助金额:
    $ 65.47万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.47万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了